New York is expected to take the lead on financial sector regulations and push for mandatory risk disclosures from large AI ...

As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

Jessica Copeland and Marc Krawiec explain that despite early provisions in the One Big Beautiful Bill Act to block state ...

Google, Meta, and CoreWeave lead an expected $90 billion wave of AI and energy investments in Pennsylvania, marking a shift ...

As AI, model-based systems engineering and digital thread strategies evolve, they're transforming how organizations define ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...

U.S. President Donald Trump is slated to deliver a message outlining his vision for America's role in the development of ...

As technology continues to reshape financial services, regulators and policy setters are embarking on a range of ...